Home › Funds › Sculptor Capital LP › GMED
Sculptor Capital LP position in GMED
GLOBUS MED INC · Health Care
Sculptor Capital LP reported holding 814,700 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$61.0M, representing 0.83% of its reported portfolio and ranking #37 among its reported holdings. Sculptor Capital LP has disclosed GMED holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Sculptor Capital LP's GMED position evolved
Sculptor Capital LP first disclosed a stake in GMED in Q4 2023 at 726,738 shares (US$38.7M). The position peaked in Q1 2026 at 3,058,000 shares, worth US$263.5M. Across 12 filings, Sculptor Capital LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 814,700 shares valued at US$61.0M — a reduction of -2,185,300 shares quarter over quarter.. Notable position changes include a 204% increase in Q1 2024 (shares rose 28% over the following quarter), a 32% increase in Q2 2025 (shares fell 3% over the following quarter), a 73% trim in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 726.74K | $38.73M | New |
| Q1 2024 | 2.21M | $118.58M | Add |
| Q2 2024 | 2.21M | $151.41M | Hold |
| Q3 2024 | 2.21M | $158.16M | Hold |
| Q4 2024 | 2.08M | $171.86M | Reduce |
| Q1 2025 | 2.09M | $153.20M | Add |
| Q2 2025 | 2.76M | $162.94M | Add |
| Q3 2025 | 3.50M | $200.44M | Add |
| Q4 2025 | 3.00M | $261.93M | Reduce |
| Q1 2026 | 3.06M | $263.48M | Add |
| Q2 2026 | 3.00M | $237.03M | Reduce |
| Q3 2026 | 814.70K | $61.02M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 35 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$239.4M), Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 3.20M sh · $239.44M · Q3 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
More on Sculptor Capital LP
FAQ
How long has Sculptor Capital LP held GMED?
Sculptor Capital LP has disclosed GMED holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Sculptor Capital LP's current position in GMED?
As of Q3 2026, Sculptor Capital LP holds 814.70K shares of GMED (GLOBUS MED INC), valued at $61.02M, representing 0.83% of its reported portfolio and ranking #37.
Has Sculptor Capital LP been buying or selling GMED?
In the latest 13F filing (Q3 2026), Sculptor Capital LP reduced its position in GMED. The position peaked in Q1 2026 at 3.06M shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Boston Trust Walden Corp, GW&K Investment Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.